NCT02493868: A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression
- State
- Completed
- Phase
- Phase 3
- People
- 719 taking part
- Started
- 1 Oct 2015
- Primary completion
- 15 Feb 2018
- Arms
- Placebo Plus Oral Antidepressant
- Results
- Posted on the registry
- 10 Jul 2015: Trial registered
- 1 Oct 2015: Trial started
- 16 Feb 2018: Trial completed
- 21 May 2019: Trial results posted